You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory d…

Article info

Article menu

Download PDFPDF

Autoinflammatory disorders
Short report
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases

Authors

  • Rim Bourguiba Sorbonne University, AP-HP, Tenon Hospital, Internal Medicine Department, 4 rue de la Chine, 75020, Paris, France; national Reference center for autoinflammatory diseases and AA amyloidosis (CEREMAIA), Tenon Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Maeva Kyheng Univ. Lille, CHU Lille, ULR 2694 - METRICS : évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France, CHU Lille, Département de Biostatistiques, F-59000 Lille, France, Université de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Isabelle Koné-Paut Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies Auto-Inflammatoires de l’enfant, Hôpital Bicêtre, AP HP, Université Paris Sud, Bicètre, France PubMed articlesGoogle scholar articles
  • Diane Rouzaud Department of internal medicine, Bichat hospital, Paris, France, Bichat Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Jerome Avouac Université de Paris, Service de Rhumatologie, Hôpital Cochin, AP-HP.CUP, Paris, France, Hôpital Cochin, Paris, France PubMed articlesGoogle scholar articles
  • Mathilde Devaux CHI Poissy-Saint-Germain-en-Laye, Saint-Germain-en-Laye, France PubMed articlesGoogle scholar articles
  • Nassim Ait Abdallah Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Centre de Reference des Maladies autoimmunes systemiques Rares d’Ile-de-France MATHEC, AP-HP, Hopital Saint-Louis, Paris, France, Université de Paris, IRSL, Recherche clinique appliquée à l’hématologie, EA, Paris, France, Hôpital Saint-Louis, Paris, France PubMed articlesGoogle scholar articles
  • Bruno Fautrel Sorbonne Université – Assistance Publique Hôpitaux de Paris, Pitié Salpêtrière University Hospital, Dept of Rhumatology, Reference Center for Rare Diseases CEREMAIA (ERN RITA), Paris, France. ii) Pierre Louis Institute of Epidemiology and Public Health, INSERM UMRS 1136, PEPITES team, Assistance Publique-Hopitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Nicole Ferreira-Maldent Internal Medecine, CHU Tours, Tours, France PubMed articlesGoogle scholar articles
  • Vincent Langlois GH du Havre-Hôpital Jacques Monod, Le Havre, France PubMed articlesGoogle scholar articles
  • Emmanuel Ledoult Service de Médecine Interne, Centre de Référence des Maladies Auto-immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, F-59000 Lille, France 2- Inserm, U1286, F-59000 Lille, France, CHRU de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Hubert Nielly Hôpital d'Instructions des Armées Bégin, Saint Mande, France PubMed articlesGoogle scholar articles
  • Viviane Queyrel Rheumatology department, CHU de Nice, Nice, France PubMed articlesGoogle scholar articles
  • Jérémie Sellam Rheumatology, INSERM UMRS_938, Sorbonnes Université UPMC Univ Paris 06, St-Antoine Hospital, DHU i2B, Paris, France PubMed articlesGoogle scholar articles
  • Nathalie Tieulie Service de Rhumatologie, Hôpital Pasteur, Centre Hospitalier Universitaire, Université de Nice Sophia Antipolis, Nice, France PubMed articlesGoogle scholar articles
  • Pascal Chazerain Internal Medicine and Rheumatology, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France PubMed articlesGoogle scholar articles
  • Philippe Evon Internal Medecine department, CH de Bar-Le-Duc, Bar-le-Duc, France PubMed articlesGoogle scholar articles
  • Julien Labreuche Univ Lille, Lille, France PubMed articlesGoogle scholar articles
  • Léa Savey Sorbonne University, AP-HP, Tenon Hospital, Internal Medicine Department, 4 rue de la Chine, 75020, Paris, France; national Reference center for autoinflammatory diseases and AA amyloidosis (CEREMAIA), Tenon Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Veronique Hentgen CeReMAI-Departement of Pediatrics Department of general pediatrics, Andre Mignot hospital, Versailles, CEREMAIA, France, Hôpital Mignot, Le Chesnay, France PubMed articlesGoogle scholar articles
  • Gilles Grateau Sorbonne University, AP-HP, Tenon Hospital, Internal Medicine Department, 4 rue de la Chine, 75020, Paris, France; national Reference center for autoinflammatory diseases and AA amyloidosis (CEREMAIA), Tenon Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Sophie Georgin-lavialle Sorbonne University, AP-HP, Tenon Hospital, Internal Medicine Department, 4 rue de la Chine, 75020, Paris, France; national Reference center for autoinflammatory diseases and AA amyloidosis (CEREMAIA), Tenon Hospital, Paris, France PubMed articlesGoogle scholar articles
  • FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Google scholar articles
  1. Correspondence to Dr Sophie Georgin-lavialle; sophie.georgin-lavialle{at}aphp.fr
View Full Text

Citation

Bourguiba R, Kyheng M, Koné-Paut I FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors, et al
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases
RMD Open 2022;8:e002063. doi: 10.1136/rmdopen-2021-002063

Publication history

  • Received October 27, 2021
  • Accepted February 4, 2022
  • First published May 10, 2022.
Online issue publication 
May 10, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.